Introduction {#s01}
============

The thymus supports the development of BM-derived lymphoid progenitors into mature T cells through positive and negative selection. The population of mature T cells egressing from the thymus exhibits a diverse repertoire of antigen recognition capable of mounting effective protective immunity, yet lacking autoreactivity. Tight regulation of thymic egress ensures full maturation and prevents potentially dangerous autoreactive T cells from entering the circulation ([@bib15]). Although the vast majority of thymocytes are eventually culled through the processes of positive and negative selection, ∼2% reach the final stage of maturity, exiting from the thymus and entering into the circulation ([@bib2]).

Thymic egress is an actively regulated process. Mature T cells egress from the thymus by chemotaxis in response to a sphingosine-1-phosphate (S1P) gradient ([@bib36]). S1P levels are highest in plasma and lowest in the lymphoid organs ([@bib34]). S1P is a ubiquitous bioactive sphingolipid that regulates diverse immunological functions including hematopoietic cell trafficking, vascular permeability, and mast cell activation ([@bib39]). S1P mediates many of its actions by signaling through its five cognate G protein--coupled receptors, S1P~1--5~. In the final stages of their maturation, thymocytes up-regulate the transcription factor Krüppel-like factor 2 and its target gene S1P~1~ ([@bib7]). S1P~1~ expression on mature single-positive (SP) cells enables their entry into the circulation after encountering extracellular S1P produced by neural crest--derived perivascular cells located at the corticomedullary junction ([@bib25]; [@bib49]). There is evidence that activation of thymocytes such as by antigen challenge, infection, and cytokines is capable of modulating T cell export from the thymus ([@bib28]). However, the mechanisms responsible for this phenomenon are poorly understood.

Two sphingosine kinases are capable of phosphorylating sphingosine to form S1P, and five lipid phosphatases are capable of dephosphorylating S1P, thereby regenerating sphingosine ([@bib31]). In contrast to this reversible reaction, the enzyme S1P lyase (SPL), a resident protein of the ER membrane, degrades S1P irreversibly, providing global control over circulating and tissue S1P levels ([@bib31]). SPL expression is robust in mouse thymus starting early in development and continuing through adult life ([@bib5]; [@bib27]). A critical role for SPL in lymphocyte egress was revealed when the food additive tetrahydroxybutylimidazole was shown to cause lymphopenia via SPL inhibition ([@bib36]). Similarly, genetically modified mice globally deficient in SPL are lymphopenic ([@bib43]). The lymphopenia associated with SPL suppression is presumed to result from disruption of the S1P gradient maintained by thymic SPL activity ([@bib36]). Both S1P~1~ antagonism and SPL inhibition have been explored as therapeutic strategies for treatment of autoimmune disease by blocking lymphocyte egress from the thymus and peripheral lymphoid organs ([@bib18]; [@bib1]; [@bib46]).

Despite the importance of S1P signaling in lymphocyte trafficking, little is known about the compartmentalization of S1P metabolism in the thymus and the cell types responsible for producing the S1P gradient. Thymic stromal cells provide the matrix and signaling cues necessary to foster proper thymocyte development. The stroma contains thymic epithelial cells (TECs) and vascular and perivascular cells, as well as BM-derived antigen-presenting cell types including macrophages, B cells, and DCs ([@bib35]). B cells and DCs make up a small percentage of the stroma and are located mainly in the medulla and corticomedullary region ([@bib29]). Thymic DCs have been shown to cross-present self-antigens acquired from medullary TECs to developing thymocytes and to facilitate the generation of regulatory T cells ([@bib17]; [@bib21]). Peripheral DCs can recirculate to the thymus and also contribute to thymocyte selection events ([@bib4]; [@bib30]). However, a role for DCs in homeostatic regulation of mature T cell egress from the thymus has not been identified.

In this study, we sought to identify the stromal cell population responsible for metabolizing S1P and thereby maintaining the chemical gradient required for thymic egress. Importantly, these studies identify DCs as metabolic gatekeepers of thymic egress. Combined with their role as mediators of central tolerance, DCs are thus poised to provide homeostatic regulation of thymic export.

Results {#s02}
=======

SPL expression in TECs is not required for lymphocyte egress {#s03}
------------------------------------------------------------

To determine the anatomical regions in which SPL is expressed, we performed immunofluorescence staining to detect SPL in thymuses of adult C57BL/6 mice. Costaining with UEA-1, a marker of the thymic medulla, was used to delineate cortical and medullary thymic regions. Strong SPL expression was observed in both cortical and medullary regions of the thymus ([Fig. 1 A](#fig1){ref-type="fig"}). The SPL expression pattern observed in the thymic cortex was reticular and suggested robust expression in thymic stroma. Western blotting of lysates prepared from enriched thymic stromal cells or thymocytes further established that SPL is abundantly expressed in thymic stromal cells but is expressed at barely detectible levels in thymocytes ([Fig. 1 B](#fig1){ref-type="fig"}). A major cellular component of the stroma is the TEC, wherein SPL is highly expressed ([@bib5]). To confirm these findings, immunofluorescence microscopy was performed on frozen sections of WT mouse thymuses costained using antibodies against SPL and the epithelial marker cytokeratin 8 (CK8). SPL expression was robust in TECs, overshadowing SPL expression in any other thymic cell type ([Fig. 1 C](#fig1){ref-type="fig"}).

![**SPL is highly expressed in TECs.** (A) Confocal microscopy of WT thymus sections. 6-µm cryosections were fixed and stained with a lectin delineating the medulla (UEA-1), SPL antibody, and Hoechst to stain the nuclei. The top row shows one lobe of the thymus. The bottom row shows a close-up image of the cortex (C) and medulla (M). Dotted lines delineate the corticomedullary junction. SPL is expressed in all sections of the thymus. Bars, 100 µm. Images are representative of three thymuses analyzed. (B) Western blotting to detect SPL in whole cell extracts of thymocytes and thymic stromal cells separated by mechanical dissociation. Actin was used as a loading control. (C) SPL expression in TECs by immunofluorescence detection and confocal microscopy. Thymic sections from WT mice were stained for CK8 to detect TECs and SPL. DAPI staining (blue) indicates nuclei. The merged image shows SPL colocalizing with CK8. The image is representative of three thymuses analyzed. Bar, 20 µm. Shown are the representative results of three independent experiments.](JEM_20160287_Fig1){#fig1}

To determine the role of TEC SPL in thymic egress, we crossed mice harboring a floxed allele for *Sgpl1* (*Sgpl1^fl/fl^*) previously generated in our laboratory ([@bib10]) with transgenic mice in which the *Cre* transgene was under the control of the *FoxN1* promoter. *FoxN1* drives recombination of floxed alleles in both cortical and medullary TECs ([@bib14]). *Sgpl1^fl/fl^FoxN1*-Cre (designated SPL^TECKO^) mice appeared healthy. To confirm gene recombination in SPL^TECKO^ mice, Western blotting was performed to detect SPL in tissue homogenates of whole thymuses from *Sgpl1^fl/fl^* (designated SPL^F^) and SPL^TECKO^ mice. As shown in [Fig. 2 A](#fig2){ref-type="fig"}, SPL expression was nearly absent in thymuses from SPL^TECKO^ mice. In contrast, no appreciable difference in SPL levels was observed in the splenic stromal cells of SPL^TECKO^ and SPL^F^ mice, demonstrating that absence of SPL expression was restricted to the thymus ([Fig. 2 B](#fig2){ref-type="fig"}). Furthermore, thymic sections from SPL^TECKO^ mice stained with SPL antibody showed no detectable SPL in CK8^+^ cells, indicating highly efficient recombination in TECs ([Fig. 2 C](#fig2){ref-type="fig"}).

![**SPL deficiency in TECs does not affect thymic egress.** (A and B) Western blots detecting SPL expression in homogenates of SPL^F^ and SPL^TECKO^ mouse thymuses (A) and spleens (B). Actin was used as a loading control. SPL expression is lost in the thymus but not the spleen of SPL^TECKO^ mice. (C) Immunofluorescence detection of SPL in frozen thymic sections from SPL^F^ and SPL^TECKO^ mice using CK8 to detect TECs, SPL antibody, and DAPI (blue). At the bottom (SPL^TECKO^), typical stromal staining for SPL is lost. Bar, 20 µm. Images are representative of three mice analyzed. (D) Flow cytometric analysis dot plots of total thymocytes in the thymuses of representative SPL^F^ and SPL^TECKO^ mice. Numbers indicate percentage of cells in the indicated quadrant. (E) Absolute numbers of CD4SP, CD8SP, and mature CD4SP cells in thymuses of SPL^F^ and SPL^TECKO^ mice (*n* = 6 mice/group for mature CD4SP, and *n* = 8 mice/group in CD4SP and CD8SP cells). (F) Flow cytometric analysis dot plots of CD4SP thymocytes of representative SPL^F^ and SPL^TECKO^ mice. Mature CD4SP and CD8SP T cells were gated as CD62L^Hi^CD69^Lo^. Numbers indicate percentage of cells in the indicated gate. (G) Absolute numbers of CD4^+^ and CD8^+^ T cells in the spleens and blood of SPL^F^ and SPL^TECKO^ mice as indicated (Spleen analysis: SPL^F^, *n* = 11; SPL^TECKO^, *n* = 11. Blood analysis: SPL^F^, *n* = 8; SPL^TECKO^, *n* = 8). (E and G) Graphs represent a compilation of four independent experiments. (H) Dot plots show CD4^+^ and CD8^+^ T cells in lymph fluid, collected from the thoracic duct, from SPL^F^ and SPL^TECKO^ representative mice. Percentages correspond to the indicated gate. (I) S1P~1~ cell surface expression on mature CD4SP T cells from representative SPL^F^ and SPL^TECKO^ mice. The gray histogram denotes negative isotype control, and blue and red histograms denote a representative of SPL^TECKO^ and SPL^F^, respectively. (J) Quantification of mean fluorescence intensity (MFI) of S1P~1~ (*n* = 3 mice/group). The results shown are representative of two independent experiments. (E, G, and J) Data are shown as mean ± SD for two-tailed unpaired Student's *t* tests.](JEM_20160287_Fig2){#fig2}

To test whether SPL^TECKO^ mice exhibit a block in lymphocyte egress, absolute numbers of SP and mature T cells were measured in thymuses of SPL^F^ and SPL^TECKO^ mice. We found no difference in the absolute numbers or percentages of mature CD4SP (CD4^+^CD8^−^CD62L^Hi^CD69^lo^) cells among total CD4SP (CD4^+^CD8^−^) thymocytes in SPL^TECKO^ mice compared with SPL^F^ ([Fig. 2, E and F](#fig2){ref-type="fig"}). Similarly, no difference was detected in absolute numbers and percentages of CD4SP and CD8SP thymocytes between the two groups ([Fig. 2, D and E](#fig2){ref-type="fig"}). In addition, loss of SPL expression in TECs had no impact on the percentage or absolute numbers of T cells in secondary lymphoid organs, blood, and lymph of SPL^TECKO^ mice when compared with SPL^F^ ([Fig. 2, G and H](#fig2){ref-type="fig"}).

Elevation of S1P levels in the thymus by pharmacological agents or genetic approaches disrupts the S1P gradient and impairs the exit of mature SP cells from the thymus to blood ([@bib36]; [@bib43]; [@bib45]). To explore the effect of SPL deficiency in TECs on the S1P gradient, S1P levels in thymuses and plasma were measured by liquid chromatography (LC) mass spectrometry (MS). Despite the high SPL expression in TECs, SPL^TECKO^ mice showed no appreciable difference in thymic or plasma S1P levels compared with SPL^F^, as shown in [Fig. 3 (A and B)](#fig3){ref-type="fig"}.

![**S1P levels in thymus and plasma.** (A and B) S1P levels in mouse thymuses (A) and plasma (B) of various mouse lines. Solid dots represent individual SPL^F^ control, and squares represent specific SPLKO indicated at the bottom of the graph. Three to five mice per group were analyzed. Mean values ± SD are shown. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P ≤ 0.001 for two-tailed unpaired Student's *t* tests between SPL^F^ and each KO strain. Shown is a representative of two independent experiments.](JEM_20160287_Fig3){#fig3}

Upon binding to extracellular S1P within their local environment, mature T cells internalize S1P~1~, and high local S1P levels produce sustained receptor internalization ([@bib23]). The surface S1P~1~ expression level in mature SP T cells of SPL^TECKO^ mice was similar to that of SPL^F^ ([Fig. 2, I and J](#fig2){ref-type="fig"}). This finding suggested that the S1P levels in the vicinity of mature SP T cells were not sufficiently different from controls to influence S1P~1~ residence time at the plasma membrane. Collectively, these results show that the pool of SPL residing within TECs has no influence on the S1P gradient and, thus, no influence on thymic egress.

Endothelial cell SPL is not essential for mediating thymic egress {#s04}
-----------------------------------------------------------------

Besides TECs, the thymus is largely comprised of vascular or BM-derived blood cells. To explore whether SPL contained in endothelial and blood cells are required for lymphocyte egress, we crossed *Sgpl1^fl/fl^* mice with *Mx1-Cre* mice, wherein *Cre* transgene expression is driven by the interferon-inducible *Mx1* promoter. The resulting *Sgpl1^fl/fl^Mx1*-Cre mice can be induced to undergo recombination of *Sgpl1* in interferon-sensitive cells by treatment with the interferon inducer polyinosinic:polycytidylic acid (poly\[I:C\]; [@bib19]). *Sgpl1^fl/fl^Mx1*-Cre pups were induced at 1 wk of age with poly(I:C). Henceforth, these are referred to as SPL^Mx1KO^ mice. In SPL^Mx1KO^ mice, SPL expression was significantly reduced in blood cells, undetectable in spleen, and modestly decreased in liver ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast, there was no notable difference in thymic SPL expression between SPL^Mx1KO^ and SPL^F^ mice ([Fig. 4 A](#fig4){ref-type="fig"}). These results establish the efficiency of recombination in the SPL^Mx1KO^ mice and confirm that TECs represent the main source of thymic SPL.

![**SPL deficiency in BM and endothelial cells blocks thymic egress.** (A) Western blotting to detect SPL in homogenates of spleens, white blood cells, liver, and thymuses isolated from SPL^F^ and SPL^Mx1KO^ mice. Actin antibody was used as a loading control. (B) Flow cytometric analysis dot plots of total thymocytes of representative SPL^F^ and SPL^Mx1KO^ mice. Numbers indicate the percentage of cells in the indicated gate. (C) Flow cytometric analysis dot plots of CD4SP thymocytes of representative SPL^F^ and SPL^Mx1KO^ mice. Mature CD4SP and CD8SP T cells were gated as CD62L^Hi^CD69^Lo^. Numbers indicate percentage of cells in the indicated gate. (D) Absolute numbers of CD4SP and CD8SP in SPL^F^ and SPL^Mx1KO^ mice corresponding to the dot plot shown in B, summarized in graph format. (E) Absolute numbers of mature CD4SP and mature CD8SP from SPL^F^ and SPL^Mx1KO^ mice corresponding to the dot plot shown in C, summarized in graph format. (F) Absolute numbers of T cells in the mesenteric LNs, blood, spleen, and lymph fluid of SPL^F^ (black bars) and SPL^Mx1KO^ (white bars) mice. (D--F) *n* = 8 mice/group. Graphs represent a compilation of three independent experiments. (G) S1P~1~ surface abundance on mature CD4SP T cells in representative SPL^F^ or SPL^Mx1KO^ mice. The gray histogram represents a negative isotype control. (H) Quantification of mean fluorescence intensity (MFI) of S1P~1~ (*n* = 3 mice/group). Shown is a representative of two independent experiments. (D--F and H) Mean values ± SD are shown. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P ≤ 0.001 for two-tailed unpaired Student's *t* tests between SPL^F^ and SPL^Mx1KO^ mice.](JEM_20160287_Fig4){#fig4}

We next examined whether thymic egress was compromised in SPL^Mx1KO^ mice lacking SPL in both hematopoietic and endothelial cells. We observed a twofold increase in CD4SP and CD8SP, as well as a fivefold increase in mature CD4SP and mature CD8SP T cells in the thymuses of SPL^Mx1KO^ mice compared with SPL^F^ mice ([Fig. 4, B--E](#fig4){ref-type="fig"}). A concomitant depletion of CD4^+^ and CD8^+^ T cells was observed in the blood, lymph, spleens, and mesenteric LNs of SPL^Mx1KO^ mice compared with SPL^F^ mice ([Fig. 4 F](#fig4){ref-type="fig"}).

To investigate how loss of SPL expression in hematopoietic and endothelial cells affected the S1P gradient, we measured S1P levels in thymuses and plasma. We observed a striking 12-fold increase in thymic S1P levels but no change in plasma S1P levels in SPL^Mx1KO^ mice compared with SPL^F^ mice ([Fig. 3, A and B](#fig3){ref-type="fig"}). Furthermore, the surface expression of S1P~1~ in mature CD4SP cells of SPL^Mx1KO^ mice was reduced by two thirds compared with that of mature CD4SP cells of SPL^F^ mice, indicating that the mature T cells were encountering very high local extracellular S1P levels, i.e., disruption of the S1P gradient ([Fig. 4, G and H](#fig4){ref-type="fig"}).

These findings suggest that SPL is required in endothelial cells, hematopoietic cells, or both to maintain the S1P gradient and support mature T cell egress. To distinguish among these possibilities, we first investigated the contribution of endothelial SPL to thymic output. To analyze the expression of SPL in endothelial cells, frozen sections of thymuses from SPL^F^ mice were coimmunostained using antibodies against SPL and the endothelial marker CD31. Colocalization of SPL and CD31 signals demonstrated that endothelial cells express SPL ([Fig. 5 A](#fig5){ref-type="fig"}). We then crossed *Sgpl1^fl/fl^* mice with *Cdh5*(PAC)-*Cre*ERT2 transgenic mice, which upon induction with tamoxifen resulted in endothelial-specific recombination of the *Sgpl1* gene ([@bib44]). Thymic sections from tamoxifen-induced *Sgpl1^fl/fl^Cdh5*(PAC)-*Cre*ERT2 mice (designated SPL^VEKO^) and controls were coimmunostained with SPL and CD31 antibodies, and thymic endothelial cells (CD31^+^ CD45^−^ CK8^−^) were sorted and analyzed by Western blotting. Thymic endothelial cells from SPL^VEKO^ mice lacked SPL expression, confirming efficient recombination ([Fig. 5, A--C](#fig5){ref-type="fig"}).

![**SPL deficiency in endothelial cells does not block thymic egress.** (A) Immunofluorescence was performed on frozen thymic sections from SPL^F^ and SPL^VEKO^ mice using CD31, SPL antibody, and DAPI (blue) followed by staining with fluorophore-conjugated secondary antibodies. Dotted lines delineate a blood vessel. Bar, 100 µm. Images shown are representative of five thymuses analyzed. (B) Western blot of whole-cell extracts of thymic endothelial cells (CD31^+^ CD45^−^ CK8^−^) isolated from SPL^F^ and SPL^VEKO^ mice. GAPDH was used as a loading control. (C) Relative intensity of Western blot bands of SPL/GAPDH. The results shown are representative of two independent experiments. (D) Absolute number of CD4SP and mature CD4SP T cells from SPL^F^ and SPL^VEKO^ mice. (E) Absolute numbers of CD4^+^ and CD8^+^ T cells in the blood, mesenteric LN, and spleen. (D and E) Graphs represent a compilation of four independent experiments. SPL^F^, *n* = 7; SPL^VEKO^, *n* = 12. (F) S1P~1~ surface abundance on mature CD4SP T cells in representative SPL^F^ and SPL^VEKO^ mice. The gray histogram shows a negative isotype control. (G) Quantification of mean fluorescence intensity (MFI) of S1P~1~ (SPL^F^, *n* = 3; SPL^VEKO^, *n* = 3). The results shown are representative of two independent experiments. (D, E, and G) Data are shown as mean ± SD for two-tailed unpaired Student's *t* tests.](JEM_20160287_Fig5){#fig5}

SPL^VEKO^ mice exhibited normal thymic egress, as demonstrated by a lack of retained CD4SP and mature CD4SP T cells in the thymus ([Fig. 5 D](#fig5){ref-type="fig"}), and no difference from SPL^F^ mice in the number of T cells in secondary lymphoid organs and blood ([Fig. 5 E](#fig5){ref-type="fig"}). Analysis of S1P levels in the thymuses and plasma of SPL^VEKO^ mice revealed no significant differences compared with SPL^F^ ([Fig. 3, A and B](#fig3){ref-type="fig"}). Mature CD4SP T cells of SPL^VEKO^ mice also expressed similar levels of surface S1P~1~ as those of SPL^F^, indicating appropriately low extracellular S1P levels in their vicinity ([Fig. 5, F and G](#fig5){ref-type="fig"}). Thus, SPL activity in the endothelial cell compartment is not essential for generating the S1P gradient or promoting thymic egress.

A hematopoietic cell type harbors the SPL activity required for thymic egress {#s05}
-----------------------------------------------------------------------------

Our findings suggested that SPL deficiency in a hematopoietic cell type was responsible for the retention of mature SP T cells observed in SPL^Mx1KO^ mice. To confirm this hypothesis, BM reconstitution experiments were performed in which irradiated SPL^Mx1KO^ mice were transplanted with BM from WT CD45.1 congenic mice. We showed that BM transplantation effectively rescued the thymic egress defect of SPL^Mx1KO^ mice, as shown by the normal proportions of mature CD4SP T cells in the thymus and normal T cell numbers in the peripheral blood 7 wk after transplantation ([Fig. 6, A--D](#fig6){ref-type="fig"}). In parallel, the block in thymic egress observed in SPL^Mx1KO^ mice could be recapitulated in WT CD45.1 congenic mice transplanted with BM from SPL^Mx1KO^ mice, whereas WT mice transplanted with WT BM exhibited normal egress ([Fig. 6, A--D](#fig6){ref-type="fig"}). These findings confirm that SPL is required in BM-derived hematopoietic cells to promote mature T cells' egress from the thymus.

![**SPL expression is required in hematopoietic cells for thymic egress.** (A--D) SPL^Mx1KO^ or congenic CD45.1 (WT) mice were lethally irradiated, and BM was reconstituted from SPL^Mx1KO^ or WT mice as indicated. Chimeric mice were analyzed 7 wk after transplantation. (A) Dot plots show CD4SP thymocytes and mature CD4SP cells gated as CD62L^Hi^CD69^Lo^ from a representative recipient mouse. Numbers indicate percentage of cells in the indicated gate. (B) Absolute numbers of mature CD4SP T cells among CD4SP cells are summarized in graph format (*n* = 3--6 mice/group). (C) Flow cytometric analysis dot plots of blood lymphocytes in representative recipient mice reconstituted from SPL^Mx1KO^ or WT mice as indicated. Numbers indicate percentage of CD4^+^ and CD8^+^ T cells. (D) Absolute numbers of CD4^+^ and CD8^+^ T cells in the blood and spleen of WT recipients transplanted with WT marrow (black bars), WT recipients transplanted with SPL^Mx1KO^ marrow (white bars), and SPL^Mx1KO^ recipients transplanted with WT marrow (green bars) are summarized in bar graph format (*n* = 3--6 recipient mice/group). (B and D) Graphs represent a compilation of three independent experiments. Mean values ± SD are shown. \*, P \< 0.05; \*\*, P \< 0.01 for two-tailed unpaired Student's *t* tests between recipient mice as indicated.](JEM_20160287_Fig6){#fig6}

SPL expression in mature T cells contributes to efficient thymic egress {#s06}
-----------------------------------------------------------------------

Four major hematopoietic cell types are present in the thymus, which include thymocytes, B cells, macrophages, and DCs. To investigate the possibility that SPL activity is required in mature SP T cells to promote their egress, we generated *Sgpl1^fl/fl^CD4-Cre* (designated SPL^TCellKO^) mice, in which recombination of the floxed allele was induced in thymocytes at the double positive (DP) stage. SPL^TCellKO^ mice exhibited no detectable expression of SPL protein or *Sgpl1* messenger RNA in splenic CD4^+^ T cells and CD4^+^ thymocytes based on immunoblotting and quantitative RT-PCR, respectively ([Fig. 7, A and B](#fig7){ref-type="fig"}). We observed a twofold increase in SP and threefold increase in mature T cells in the thymuses of SPL^TCellKO^ mice compared with floxed control mice (SPL^F^), indicating that some mature T cells are retained in the thymus of SPL^TCellKO^ mice ([Fig. 7, C and D](#fig7){ref-type="fig"}). To verify that this phenotype was not associated with the *Cre* transgene itself, we analyzed a second control group that expressed the *CD4-Cre* transgene in a nonfloxed background (CD4-Cre). As expected, CD4-Cre mice exhibited a normal egress phenotype indistinguishable from that of SPL^F^ mice, confirming that CD4-Cre itself was not responsible for the mature T cell accumulation observed in SPL^TCellKO^ mice ([Fig. 7, C and D](#fig7){ref-type="fig"}). Peripheral CD4^+^ T cells were not reduced in the blood, although they were modestly reduced in the spleen compared with controls, whereas CD8^+^ T cells were increased in the mesenteric LNs of SPL^TCellKO^ mice ([Fig. 7 E](#fig7){ref-type="fig"}). Overall, the disruption of SPL in thymocytes led to retention of mature T cells but did not recapitulate the severe egress phenotype and peripheral lymphopenia characteristic of SPL null mice or SPL^Mx1KO^ mice.

![**SPL expression in mature T cells contributes to efficient egress.** (A) Western blot to detect SPL in CD45RB^Hi^CD4^+^ T cells isolated from spleens of SPL^F^ and SPL^TCellKO^ mice. Splenic T cells were sorted from SPL^F^ and SPL^TCellKO^ mice and prepared for Western blotting. Actin antibody was used as a loading control. (B) CD4^+^ thymocytes were flow sorted from SPL^F^ and SPL^TCellKO^ mouse thymuses. Purified cells were pooled from four mice/group. Gene expression of SPL (*Sgpl1*) was analyzed by quantitative real-time PCR. (C) Absolute numbers of CD4SP (CD4-Cre, *n* = 3; SPL^F^, *n* = 15; SPL^TCellKO^, *n* = 19) and CD8SP (CD4-Cre, *n* = 3; SPL^F^, *n* = 16; SPL^TCellKO^, *n* = 24) thymocytes. (D) Mature CD4SP (CD4-Cre, *n* = 3; SPL^F^, *n* = 10; SPL^TCellKO^, *n* = 18) and mature CD8SP (CD4-Cre, *n* = 3; SPL^F^, *n* = 10; SPL^TCellKO^, *n* = 20) T cells. (E) Absolute numbers of CD4^+^ and CD8^+^ T cells in the spleen, blood, and mesenteric LN of SPL^F^ and SPL^TCellKO^ mice as indicated (SPL^F^, *n* = 7; SPL^TCellKO^, *n* = 10). (C--E) Graphs represent a compilation of six independent experiments. (F) S1P~1~ surface abundance on mature CD4SP T cells in representative SPL^F^ and SPL^TCellKO^ mice as indicated. The gray histogram represents a negative isotype control. (G) Quantification of mean fluorescence intensity (MFI) of S1P~1~ (SPL^F^, *n* = 5; SPL^TCellKO^, *n* = 11). The graph represents a compilation of four independent experiments. (B--E and G) Mean values ± SD are shown. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P ≤ 0.001 for two-tailed unpaired Student's *t* tests between SPL^F^ and SPL^TCellKO^.](JEM_20160287_Fig7){#fig7}

S1P levels in the thymus of SPL^TCellKO^ mice were 12-fold higher than in SPL^F^ mice, and plasma levels were increased ([Fig. 3, A and B](#fig3){ref-type="fig"}). Furthermore, the mean S1P~1~ surface abundance on mature CD4SP T cells from SPL^TCellKO^ mice was reduced compared with that of SPL^F^ mice, indicating SPL^TCellKO^ mature T cells were encountering higher than normal local extracellular S1P levels ([Fig. 7, F and G](#fig7){ref-type="fig"}). These cumulative results demonstrate that SPL intrinsic to mature T cells facilitates their efficient egress from the thymus but is unlikely to represent the main metabolic regulator of this process.

We therefore investigated the impact of disrupting SPL function in the other major hematopoietic-derived cell types found in the thymus. We generated *Sgpl1^fl/fl^CD11b-Cre* (SPL^MacKO^) mice, which lack the expression of SPL in monocytes/macrophages, and *Sgpl1^fl/fl^CD19-Cre* (SPL^BCellKO^) mice, which lack SPL in B lymphocytes. Efficient recombination and loss of SPL expression in the target cell population of each model was confirmed by immunoblotting of whole cell extracts from purified cells ([Fig. 8, A--D](#fig8){ref-type="fig"}). Immunofluorescence microscopy of BM-derived macrophages from SPL^MacKO^ mice showed they exhibit no detectible SPL expression ([Fig. 8 E](#fig8){ref-type="fig"}). These mouse models exhibit normal total thymic S1P levels, and their mature T cells express amounts of surface S1P~1~ similar to those of SPL^F^, suggesting normal local extracellular S1P levels. Furthermore, the numbers of SP and mature T cells as well as peripheral T cells were similar to those of SPL^F^ ([Fig. 3, A and B](#fig3){ref-type="fig"}; and [Fig. 8, F--M](#fig8){ref-type="fig"}). These findings establish that neither monocyte/macrophage nor B lymphocyte SPL activities play a significant role in thymic egress.

![**SPL deficiency in monocytes/macrophages and B lymphocytes do not influence thymic egress.** (A) Western blot to detect SPL in whole-cell extracts of CD11b^+^ BM cells from SPL^F^ and SPL^MacKO^ mice. CD11b^+^ cells were isolated by magnetic cell isolation from BM cells of SPL^F^ and SPL^MacKO^ mice and prepared for Western blotting. (B) Western blot to detect SPL in thymic extracts from SPL^F^ and SPL^MacKO^ mice. (C) Western blot to detect SPL in CD11b^+^ peritoneal macrophage extracts from SPL^F^ and SPL^MacKO^ mice. Peritoneal macrophages were collected as described in Materials and methods, and CD11b^+^ peritoneal macrophages were isolated by magnetic cell isolation. (D) Western blot to detect SPL in whole-cell extracts of sorted B220^+^ B cells of SPL^F^ and SPL^BcellKO^ mice. (A--D) GAPDH antibody was used as a loading control. (E) Immunofluorescence was performed using F4/80, SPL antibody, and DAPI (blue) on BM cells that were previously differentiated into macrophages using the growth factor G-CSF. The bottom (SPL^MacKO^) shows low SPL expression. Bar, 30 µm. The results shown are representative of two independent experiments. (F) Absolute numbers of CD4SP and mature CD4SP T cells from SPL^F^ and SPL^MacKO^ mice (SPL^F^, *n* = 12; SPL^MacKO^, *n* = 11). (G) Absolute numbers of CD4SP and mature CD4SP T cells from SPL^F^ and SPL^BCellKO^ mice (SPL^F^, *n* = 8; SPL^BCellKO^, *n* = 15). (H) Absolute numbers of CD4^+^ and CD8^+^ T cells in the spleen, blood, and mesenteric LN of SPL^F^ and SPL^MacKO^ mice as indicated (SPL^F^, *n* = 8; SPL^MacKO^, *n* = 12). (I) S1P~1~ surface abundance on mature CD4SP T cells in representative SPL^F^ and SPL^MacKO^ mice. The gray histogram shows staining with negative isotype control. (J) Quantification of mean fluorescence intensity (MFI) of S1P~1~ (SPL^F^, *n* = 3; SPL^MacKO^, *n* = 3). The results shown are representative of two experiments. (K) Absolute numbers of CD4^+^ and CD8^+^ T cells in the spleen, blood, and mesenteric LN of SPL^F^ and SPL^BCellKO^ mice as indicated (SPL^F^, *n* = 8; SPL^BCellKO^, *n* = 15). (L) S1P~1~ surface abundance on mature CD4SP T cells in representative SPL^F^ and SPL^BCellKO^ mice. The gray histogram shows a negative isotype control. (M) Quantification of mean fluorescence intensity of S1P~1~ (SPL^F^, *n* = 3; SPL^BCellKO^, *n* = 3). The results shown are representative of two experiments. (F--H and K) Graphs represent a compilation of three independent experiments. (F--H, J, K, and M) Mean values ± SD are shown. \*, P \< 0.05 for two-tailed unpaired Student's *t* tests between the indicated groups.](JEM_20160287_Fig8){#fig8}

DCs harbor the metabolic activity essential for maintaining the S1P gradient and promoting thymic egress {#s07}
--------------------------------------------------------------------------------------------------------

Thymic DCs localize to the medulla and corticomedullary junction ([@bib48]) where mature T cells egress the thymic parenchyma and enter the circulation via blood vessels ([@bib49]). To determine whether DC-specific SPL activity might be responsible for the profound egress phenotype observed in SPL^Mx1KO^ mice, we first investigated whether DCs express SPL. Because robust SPL expression in TECs obscures detection of SPL in other cell types, SPL expression was analyzed in thymic sections from SPL^TECKO^ mice. DCs located in the medulla and at the corticomedullary junction were found to express SPL ([Fig. 9 A](#fig9){ref-type="fig"}).

![**SPL expression in thymic DCs is required for thymic egress.** (A) Immunofluorescence was performed on frozen thymic sections from SPL^TECKO^ mice using CD11c and SPL antibody. Bar, 100 µm. The results shown are representative of three thymuses analyzed. (B) Western blot to detect SPL in whole-cell extracts of CD11c^+^ DCs isolated from spleens and whole thymic extracts of SPL^F^ and SPL^DCKO^ mice. GAPDH antibody was used as a loading control. (C) Immunofluorescence was performed on frozen thymic sections from SPL^F^ and SPL^DCKO^ mice using CD11c, SPL antibody, and DAPI (blue) to stain the nuclei. Bar, 100 µm. The results shown are representative of three thymuses analyzed. (D) Flow cytometric analysis of total thymocytes in representative SPL^F^ and SPL^DCKO^ mice. (E) Flow cytometric analysis of CD4SP thymocytes. Mature CD4SP cells were gated as CD62L^Hi^CD69^Lo^ in representative SPL^F^ and SPL^DCKO^. (D and E) Numbers indicate percentage of cells in the indicated gate. (F) Absolute numbers of CD4SP and CD8SP SPL^F^ and SPL^DCKO^ mice corresponding to the dot plot shown in D, summarized in graph format (CD4SP: SPL^F^, *n* = 15; SPL^DCKO^, *n* = 18. CD8SP: *n* = 8/group). (G) Absolute numbers of mature CD4SP and mature CD8SP T cells from SPL^F^ and SPL^DCKO^ mice corresponding to the dot plot shown in E, summarized in bar graph format (Mature CD4: SPL^F^, *n* = 15; SPL^DCKO^, *n* = 18. Mature CD8: *n* = 8/group). (H) Absolute numbers of CD4^+^ and CD8^+^ T cells in the spleen, blood, mesenteric LN, and lymph fluid (lymph) of SPL^F^ and SPL^DCKO^ as indicated (SPL^F^, *n* = 7; SPL^DCKO^, *n* = 15). (F--H) Graphs represent a compilation of five independent experiments. (I) S1P~1~ surface abundance on mature CD4SP T cells in representative SPL^F^ and SPL^DCKO^ mice. The gray histogram shows a negative isotype control. (J) Quantification of mean fluorescence intensity (MFI) of S1P~1~ (SPL^F^, *n* = 4; SPL^DCKO^, *n* = 4). The results shown are representative of two experiments. (F--H and J) Mean values ± SD are shown. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P ≤ 0.001; \*\*\*\*, P \< 0.0001 for two-tailed unpaired Student's *t* tests between SPL^F^ and SPL^DCKO^.](JEM_20160287_Fig9){#fig9}

We then generated *Sgpl1^fl/fl^CD11c-Cre* (SPL^DCKO^) mice ([@bib40]), which lack SPL expression in DCs. Western blot analysis of CD11c^+^ DCs isolated from the spleens of SPL^DCKO^ mice showed reduced SPL expression compared with SPL^F^ DCs, confirming a DC-specific defect in SPL expression in these mice ([Fig. 9 B](#fig9){ref-type="fig"}). Whole thymus lysates of SPL^DCKO^ and control mice express similar amounts of SPL, consistent with the observation that TECs harbor the majority of thymic SPL ([Fig. 9 B](#fig9){ref-type="fig"}). However, detection of SPL and CD11c in frozen thymic sections by immunofluorescence microscopy showed that thymic DCs in SPL^DCKO^ mice indeed lack SPL expression ([Fig. 9 C](#fig9){ref-type="fig"}).

Importantly, SPL^DCKO^ mice exhibited a threefold increase in thymic accumulation of SP cells and a ninefold increase in mature T cells retained in the thymus compared with SPL^F^ controls ([Fig. 9, D--G](#fig9){ref-type="fig"}). A second control group that expresses the *CD11c-Cre* transgene in a nonfloxed background (CD11c-Cre) was indistinguishable from SPL^F^ in egress phenotype, verifying that the phenotype observed in SPL^DCKO^ was not associated with the *CD11c-Cre* transgene itself ([Fig. 9, D--G](#fig9){ref-type="fig"}). The number of T cells in the periphery was also significantly reduced in SPL^DCKO^ mice ([Fig. 9 H](#fig9){ref-type="fig"}). S1P levels were 12-fold higher in thymuses, and there was no significant change in the plasma of SPL^DCKO^ mice compared with controls, similar to the relative increase in total thymic S1P levels observed in SPL^Mx1KO^ and SPL^TCellKO^ mice ([Fig. 3, A and B](#fig3){ref-type="fig"}). In addition, the surface S1P~1~ expression in mature CD4SP T cells from SPL^DCKO^ mice was reduced by two thirds compared with SPL^F^, similar to the changes observed in SPL^Mx1KO^ mice and more than were observed in SPL^TCellKO^ mice ([Fig. 9, I and J](#fig9){ref-type="fig"}). These findings indicate that DCs have a profound impact on extracellular S1P levels in the vicinity of mature T cells.

We next tested whether disruption of SPL in mature T cells' thymic egress would enhance the egress phenotype of SPL^DCKO^ mice. To this end, we generated a double KO mouse model (SPL^DC&TCellKO^). The double KO mice exhibited the same phenotype as SPL^DCKO^ ([Fig. 9, F and G](#fig9){ref-type="fig"}). This finding demonstrates that SPL in T cells does not provide an additive contribution to DC regulation of thymic egress and that DCs are the main regulators of mature T cell egress. Our observations demonstrate that DCs play a previously unrecognized essential role in thymic egress, providing the metabolic function necessary to generate a highly localized S1P chemotactic gradient that promotes mature T cell egress.

Adoptive transplant of WT peripheral DCs rescues the SPL^DCKO^ egress phenotype {#s08}
-------------------------------------------------------------------------------

The high number of mature T cells in SPL^TCellKO^ and SPL^DCKO^ could have been a result of increase proliferation. To exclude this possibility, we measured the expression of Ki67, a protein only expressed in proliferating cells. The expression of Ki67 in SPL^DCKO^ and SPL^TCellKO^ was not significantly different from that of SPL^F^, suggesting that the high number of mature T cells in both models was not caused by an increase of proliferation ([Fig. 10 A](#fig10){ref-type="fig"}). SPL disruption in DCs could potentially influence thymic DC quantity. However, we observed no difference in the numbers of medullary DCs in SPL^DCKO^ and SPL^F^ mice ([Fig. 10 B](#fig10){ref-type="fig"}). To further confirm the critical role of DC SPL in regulating thymic egress, we took advantage of the fact that circulating DCs can migrate from the periphery to the thymus ([@bib4]; [@bib22]). To test whether circulating DCs with functional SPL could rescue the block in the mature T cell egress seen in SPL^DCKO^ mice, we performed adoptive transfer experiments in which enriched DC populations obtained from the spleens of WT and SPL^DCKO^ donor mice were administered intravenously to SPL^DCKO^ mice. To confirm the homing of DCs to the thymus, thymic sections of mice injected intravenously with DCs stained with CMTMR cell tracker dye were analyzed by immunofluorescence and flow cytometry. CMTMR^+^ cells were observed around the blood vessels, and no difference in homing efficiency was observed between WT and SPL-deficient DCs ([Fig. 10, C--F](#fig10){ref-type="fig"}). Furthermore, this population of CMTMR^+^ cells in the thymus was enriched for CD11c^+^ cells ([Fig. 10 D](#fig10){ref-type="fig"}). We showed that infusion of 60--80 × 10^6^ DCs isolated from WT donor mice into SPL^DCKO^ mice resulted in a significant reduction of mature SP T cells in the thymuses of the recipient mice, demonstrating rescue of the thymic egress retention phenotype characteristic of SPL^DCKO^ mice ([Fig. 10 G](#fig10){ref-type="fig"}). In contrast, SPL^DCKO^ mice that received infusion of DCs isolated from SPL^DCKO^ donor mice exhibited persistent retention of mature SP T cells.

![**WT DCs rescue the SPL^DCKO^ thymic egress phenotype by uptake of S1P in a S1P~1,3--5~ receptor--dependent manner.** (A) Absolute numbers of Ki67^+^ mature CD4SP T cells in SPL^F^, SPL^DCKO^, and SPL^TcellKO^ mice. The results shown are representative of two independent experiments. (B) Number of medullary DCs per unit area. The graph is created from three thymuses per group. DCs were isolated from the spleens of either WT (DC WT) or SPL^DCKO^ (DC SPL^DCKO^) donor mice as described in Materials and methods. Isolated DCs were administered intravenously into unirradiated SPL^DCKO^ mice. (C) Flow cytometry of CD11c expression of the injected DCs (input). (D) 5 d later, thymuses were collected, and single-cell suspensions were analyzed. (Left) Thymocyte suspension showing homed CMTMR^+^ cells. FSC, forward side scatter. (Right) CD11c expression on gated CMTMR^+^ cells. (C and D) Numbers above the bracketed lines indicate the frequency of CD11c^+^ events. The results shown are representative of three independent experiments. (E) Immunofluorescence was performed on frozen thymic sections from SPL^DCKO^ mice 24 h after injection using CD31 to stain the blood vessels and Hoechst (blue) to stain the nuclei. Bars, 100 µm. The results shown are representative of five thymuses analyzed. (F) Homing measured by flow cytometry for the presence CMTMR^+^ cells 5 d after injection. The graph represents a compilation of five thymuses per group. (G) 5 d after injection of DCs, SPL^DCKO^-recipient mice, as well as WT and SPL^DCKO^ control mice, were euthanized, and mature (CD62L^Hi^CD69^Lo^) CD4SP T cells were quantified by flow cytometry in whole thymuses. The graph represents a compilation of three independent experiments. (H) S1P levels in LN, spleen, and BM in SPL^F^ and SPL^DCKO^ mice. The graphs represent a compilation of two independent experiments. (I) Mature BMDCs from SPL^F^ and SPL^Mx1KO^ were incubated with 1.5 µM D7-S1P, and their uptake was measure by LC/MS over time. The results shown are representative of two independent experiments. (J) CD4SP thymocytes isolated from SPL^F^ and SPL^TCellKO^ mice were incubated with D7-S1P, and their uptake was measured by LC/MS. The results shown are representative of two independent experiments. (K) Rate of D7-S1P uptake was calculated in SPL-deficient CD4SP thymocytes and mature BMDCs. The rate of change was calculated from two independent experiments. (L) Mature BMDCs were incubated for 24 h with either 10 µM XY-14, 5 µM FTY720, 80 µM of dynasore, or DMSO vehicle control before introducing 1.5 µM D7-S1P in the medium. Intracellular D7-S1P was quantified by LC/MS. The results shown are representative of two independent experiments. (A, B, and F--L) Mean values ± SD are shown. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001 for two-tailed unpaired Student's *t* tests between the indicated groups.](JEM_20160287_Fig10){#fig10}

Combined with our other findings, these results establish that DCs play a critical metabolic role in regulating mature T cell egress from the thymus. Specifically, by providing the SPL enzyme activity that degrades extracellular S1P in the vicinity of maturing thymocytes located at the corticomedullary junction, thymic DCs generate a highly localized S1P gradient that is essential for T cells egress. S1P levels were also high in LN and spleen of SPL^DCKO^ mice, demonstrating that DCs regulate S1P levels in other organs as well ([Fig. 10 H](#fig10){ref-type="fig"}).

DCs import extracellular S1P through S1P~1,3--5~ receptors {#s09}
----------------------------------------------------------

Our findings indicate that DCs are the primary cells responsible for generating the S1P gradient in the thymus by metabolizing S1P through the actions of intracellular SPL. However, SPL is an intracellular enzyme. Thus, it was important to establish whether DCs are capable of importing S1P from the extracellular environment. Because T cell SPL had some effect on thymic egress and localized S1P levels, we also investigated the ability of SP thymocytes to take up S1P. To this end, we first generated mature BMDCs in vitro and followed their ability to take up D7-S1P, a stable isotope introduced into the medium. Mature BMDCs from SPL^F^ mice degraded D7-S1P rapidly and did not accumulate S1P, whereas those from SPL^Mx1KO^ mice accumulated D7-S1P over time ([Fig. 10 I](#fig10){ref-type="fig"}). Similarly, CD4SP thymocytes were able to take up D7-S1P ([Fig. 10 J](#fig10){ref-type="fig"}). Notably, DCs were able to take up D7-S1P at a significantly faster rate than CD4SP thymocytes ([Fig. 10 K](#fig10){ref-type="fig"}).

We hypothesized that mature DCs could import S1P and deliver it to SPL in conjunction with S1P receptor internalization by endocytosis, as has been previously reported ([@bib13]). Alternatively, uptake could be mediated by a process of endocytosis independent of S1P receptors and/or via dephosphorylation by lipid phosphatase ectoenzymes (LPPs), the latter being a common mechanism for internalization of phosphorylated molecules and shown to occur with S1P uptake by cells ([@bib50]). To inhibit endocytosis, S1P~1,3--5~ receptors, LPPs, and BMDCs were preincubated with either dynasore, FTY720, or XY-14, respectively, for 24 h before introducing D7-S1P in the media. Mature BMDCs derived from SPL^Mx1KO^ mice in which S1P~1,3--5~ receptor activity was blocked with FTY720 entirely lost their ability to take up D7-S1P, whereas inhibition of endocytosis and lipid phosphatase activities only resulted in a reduced rate of uptake ([Fig. 10 L](#fig10){ref-type="fig"}). These data demonstrate that S1P~1,3--5~ receptors are essential for DC uptake of extracellular S1P.

Discussion {#s10}
==========

In this study, we have disrupted SPL expression in a series of thymic cell populations to clarify the role of S1P metabolism in thymic egress. Our findings revealed a novel and essential metabolic function of DCs in promoting the egress of mature T cells from the thymus. DCs perform this function by generating the S1P gradient through import and irreversible SPL-catalyzed degradation of a signaling pool of extracellular S1P. Considering the location of DCs in the thymic medulla and at the corticomedullary junction, it is likely that thymic DCs produce a localized chemical gradient that stimulates the chemotaxis of mature T cells from the thymic parenchyma, where S1P levels are actively kept low toward nearby perivascular cells and the intravascular space, where S1P levels are high.

Our conclusion is based on several findings. First, we observed a severe block in thymic egress in mice lacking SPL in a restricted fashion within cells expressing the DC marker CD11c. In the model we have used, the *Cre* transgene is expressed under the control of a 160-kb genomic fragment of *Itgax* and results in recombination of the floxed allele in a highly restricted fashion in classical and plasmacytoid DCs ([@bib8]). In combination with the lack of phenotypes observed in other thymic stromal cell--specific SPL KO strains, our findings support a direct role for DCs in thymic lymphocyte egress. Second, SPL in thymic DCs is responsible for maintaining a localized S1P gradient within the immediate vicinity of mature T cells. SPL deletion in DCs caused a significant increase in the overall thymic S1P concentration (determined by S1P quantitation) and also in the immediate vicinity of mature T cells (determined by S1P~1~ expression). Third, we have shown that peripheral DCs isolated from WT mice can rescue the defect in mature T cell egress of SPL^DCKO^ mice. We used immature DCs in these studies, as they were reported to have the highest ability to home to the thymus ([@bib4]). Only WT mouse DCs and not SPL^DCKO^ mouse DCs could correct the defect in mature T cell egress in SPL^DCKO^ mice. This finding demonstrates the critical role played by SPL in DC-mediated rescue and, consequently, in mediating thymic egress. Lastly, disruption of T cell SPL did not provide any additive effect on thymocyte retention to SPL^DCKO^ mice in a double KO model, confirming the major role of DC SPL in controlling thymic egress.

DCs comprise only 0.5% of thymic cells ([@bib48]). Despite their paucity, SPL-containing thymic DCs are strategically located for degrading S1P in the interstitial space navigated by mature T cells as they move toward the blood vessels in response to S1P generated by neuronal crest--derived pericytes ([@bib49]). Our in vitro experiments establish that extracellular S1P is efficiently imported by DCs through S1P~1,3--5~ receptors. Once inside the cell, S1P can be readily transported to the ER for irreversible degradation by SPL ([@bib38]). This was illustrated by the rapid degradation of S1P by WT DCs, whereas SPL-deficient DCs accumulated intracellular S1P.

Despite having robust SPL expression, TECs do not contribute to maintaining low thymic S1P concentration and do not contribute to mature T cells' egress. This pool of SPLs could be involved in thymocyte selection, T cell repertoire, or epithelial cell differentiation, survival, or other functions. Further investigation will be required to test these possibilities.

Several proteins involved in S1P synthesis (SphKs), catabolism (SPL and LPP3), and transport (Spns2) have been identified as regulatory factors necessary for maintaining a S1P gradient between the thymus and the circulation ([@bib36]; [@bib43]; [@bib49]; [@bib12]). SPL plays an essential role in maintaining low thymic S1P levels ([@bib36]; [@bib43]). However, it remains unclear how S1P-related proteins work together to promote egress. Our experiments show that phosphatases are not essential for S1P uptake by DCs. According to [@bib6], dephosphorylation of extracellular S1P at the plasma membrane is required for its import. This may be necessary to control S1P import in other cell types but appears to have at most a minor role in DCs.

We observed that disruption of SPL in thymocytes does contribute to efficient thymic egress and localized S1P levels that influence mature T cells' S1P~1~ expression. As thymocytes develop from DP to mature T cells, their SPL expression increases significantly (unpublished data). It has been proposed that SPL is needed for S1P~1~ recycling to the cell surface, which could potentially explain our findings of reduced surface S1P~1~ on mature T cells from SPL^TCellKO^ mice ([@bib13]). Alternatively, mature T cells may require SPL to eliminate S1P export and autocrine stimulation through inside-out signaling to promote efficient chemotaxis toward the point of thymic egress ([@bib41]). SP thymocytes were also able to take up D7-S1P in vitro. However, their rate of S1P uptake was significantly lower than that of DCs. Whether chemical cues, cell--cell interactions, or other factors in the thymic microenvironment are required for S1P uptake and/or SPL activation in thymocytes remains unknown.

The similar expression of Ki67 in mature T cells of SPL^DCKO^ and SPL^TCellKO^ mice to those of floxed controls demonstrates that the high numbers of mature T cells in their thymuses are not caused by increased proliferation rates but can be attributed directly to an egress defect. Others have reported that thymocyte development is halted in global SPL KO mice because of lack of immigration and settlement of early thymic progenitors ([@bib45]). However, the absolute numbers of DP and double-negative thymocytes in SPL^DCKO^ mice were similar to floxed controls, and in SPL^TCellKO^ mice, only double-negative thymocytes were significantly elevated (unpublished data). These data demonstrate that, unlike in global SPL KO mice, settling and immigration of early thymic progenitors in SPL^DCKO^ mice is not affected.

DCs are efficient antigen-presenting cells and play a crucial role in central tolerance through diverse mechanisms ([@bib16]; [@bib47]). Our findings reveal a novel and fundamental role for DCs in the regulation of mature T cell egress, independent of their well-characterized functions in antigen presentation. There is precedent for such a role, as DCs were shown to contribute to vitamin A-- and vitamin D--mediated imprinting required to program lymphocyte homing to the small intestines and to promote T cell migration into the epidermis by processing vitamins to their active forms ([@bib37]). However, our study reveals for the first time an essential role for DCs in the direct control of mature T cell egress from the thymus. Peripheral DCs appear to control S1P in LNs and spleen, as high levels of S1P were observed in SPL^DCKO^ mice. Considering the ability of peripheral DCs to recirculate to the thymus, DCs are in a unique position to provide homeostatic regulation of global thymic output in response to events in the periphery. Thymic output is an actively regulated process and can be influenced by systemic or thymic infection, antigenic challenge, aging, and prematurity, and a variety of cytokines ([@bib42]; [@bib28]). DCs are mediators of the crosstalk between the periphery and the thymus. Their ability to modulate thymic egress in response to information in the periphery by regulating the metabolism of extracellular S1P and controlling S1P levels in secondary lymphoid organs is highly intriguing. This could provide important avenues for modulating thymic egress for therapeutic benefit.

Although in this study we have focused on the role of SPL in T cell trafficking, other immune cells also depend on S1P gradients ([@bib9]). In a preliminary analysis, we observed an accumulation of B cells in the LNs of SPL^TCellKO^, SPL^BCellKO^, and SPL^DCKO^ mice, but only SPL^DCKO^ showed accumulation of B cells in the spleen (unpublished data). These data further support the critical role of DCs in regulating lymphocyte trafficking through S1P metabolism.

In summary, our study has unveiled a novel metabolic role of thymic DCs in adaptive immunity, namely the generation of a localized S1P gradient essential for mature T cell egress. Thus, in addition to the well established role of DCs in antigen presentation and the development of central tolerance, DCs also are metabolic gatekeepers of lymphocyte trafficking. DCs are thus poised to exert control over thymic output in response to environmental conditions. We have also shown that intrinsic SPL expression in mature T cells facilitates their egress but does not provide additive effects to the major role of DC SPL in controlling thymic egress. Our findings provide a deeper understanding of the regulation of lymphocyte egress and the role of S1P metabolism in adaptive immunity. These findings are relevant to understanding changes in adaptive immunity and may reveal novel therapeutic strategies in a variety of clinical contexts including prematurity, childhood infections and immunizations, chronic infections, cancer, and thymic reconstitution after BM transplantation.

Materials and methods {#s11}
=====================

Animals {#s12}
-------

*Sgpl1^fl/fl^* mice were generated in our laboratory and were backcrossed into the C57BL/6 background for at least six generations as previously described ([@bib10]). All other mouse lines are in C57BL/6 background and backcrossed for at least six generations. C57BL/6 WT (CD45.2) and congenic CD45.1 (B6.SJL-*Ptprc^a^*/BoyAiTac) and CD4-Cre B6.Cg-Tg(*CD4*-cre)1Cwi N9 ([@bib20]) mice were purchased from Taconic. *FoxN1*-Cre mice ([@bib14]) were provided by N. Manley (University of Georgia, Athens, GA). Mx1-Cre (C.Cg-Tg\[*Mx1*-cre\]1Cgn/J; [@bib19]), CD11c-Cre (B6.Cg-Tg\[*Itgax*-cre\]1-1Reiz/J; [@bib8]), and CD19-Cre (C.Cg-*Cd19^tm1\[cre\]Cgn^ Igh^b^*/J; [@bib33]) mice were from The Jackson Laboratory. CD11b-Cre mice were provided by J. Vacher (Institut de recherches cliniques de Montréal, Montréal, Québec, Canada; [@bib11]). *Cdh5*(PAC)-CreERT2 mice were provided by R.H. Adams (Max Planck Institute for Molecular Biomedicine, Münster, Germany; [@bib44]). CD4-Cre (Tg\[*Cd4-cre*\]1Cwi/BfluJ) and CD11c-Cre (B6.Cg-Tg\[Itgax-cre\]1-1Reiz/J) control mice were purchased from The Jackson Laboratory. T cell and DC double KO mice were generated through breeding and verified by using specific primers for *CD4-Cre* (forward, 5′-TCTCTGTGGCTGGCAGTTTCTCCA-3′; and reverse 5′-TCAAGGCCAGACTAGGCTGCCTAT-3′) and *CD11c-Cre* (forward, 5′-ACTTGGCAGCTGTCTCCAAG-3′; and reverse, 5′-GCGAACATCTTCAGGTTCTG-3′) in a *Sgpl1^fl/fl^* background. Mice were housed in an AAALAC-accredited animal facility at the University of California, San Francisco Benioff Children's Hospital Oakland. All animal experiment protocols were approved by the Institutional Animal Care and Use Committee and were in accordance with the National Institutes of Health guidelines for use of live animals. For all different KO characterization and BM transplantation studies, mice were used between 6--8 wk of age or, for rescue studies, recipient mice were 13 wk old and donors were between 6 and 15 wk old. To study mice of the same age, in each experiment, SPL^F^ (Cre^−^/SPL floxed) and KO (Cre^+^/SPL floxed) mice from the same litter were compared. Variation of absolute number of cells between experiments is accredited to the range of ages at which different litters were examined.

To induce recombination by *Mx1-Cre*, 1-wk-old mice received three doses of 25 mg/kg body weight low molecular weight poly(I:C) (InvivoGen) every 48 h through intraperitoneal route. To induce Cre activity in *Sgpl1^fl/fl^Cdh5*(PAC)-*Cre*ERT2 and gene deletion, mice were injected with 500 µg tamoxifen (T5648; Sigma-Aldrich) by intraperitoneal route every day from P10 to P15.

Antibodies {#s13}
----------

SPL-specific antibody has been described previously ([@bib5]; [@bib27]). Actin antibody and Hoechst stain solution were procured from Sigma-Aldrich. Fluorochrome- or biotin-conjugated monoclonal antibodies, CD4-efluor 450 (clone RM4-5), CD4-FITC (clone RM4-4), CD8-FITC (clone 53-6.7), CD8-PE (clone 53-6.7), CD62L-PerCP-Cy5.5 (clone MEL-14), CD69-PE-Cy7 (clone H1.2F3), B220-APC (clone RA3-6B2), CD45.1-PE (clone A20), CD45.2-APC (clone 104), CD45RB-APC (clone C363.16A), and CD11c-biotin (clone N4118) were from eBioscience. Antibodies against CK8 (clone TROMA-1-C) and CD31 (clone 2H8-C) were from Developmental Studies Hybridoma Bank. F4/80 antibody (clone A3-1) and CD45-FITC (clone YW62.3) were from AbD Serotec. Ki67 antibody was from Vector Laboratories.

Cell dissociation and immunoblotting {#s14}
------------------------------------

Frozen tissues (thymus, spleen, vascular aorta, liver, and BM), cells isolated by mechanical dissociation by gently disrupting soft tissues with a homogenizer, or bead-isolated cells were homogenized in lysis buffer containing 20 mM Tris-HCl, pH 7.4, 137 mM NaCl, and 1% Triton X-100. Lysis buffer was supplemented with protease inhibitors (PMSF and protease inhibitor cocktail; Roche), 1 mM sodium orthovanadate, and 10 mM sodium fluoride. Proteins were separated on SDS-PAGE and transferred by electroblotting to nitrocellulose membranes. Immunoblotting was performed using SDS-PAGE Western blotting. Immunoreactive bands were detected by enhanced chemiluminescence (Thermo Fisher Scientific). To quantify SPL expression in thymic endothelial cells, the relative intensity of bands on Western blot autoradiograms was quantified using ImageJ (National Institutes of Health).

Flow cytometry and cell sorting {#s15}
-------------------------------

Thymus, spleen, and mesenteric LNs were harvested and dispersed into single-cell suspensions by forcing the tissue through a 70-µm cell strainer (Thermo Fisher Scientific). Blood was collected from either retroorbital route or cardiac puncture. RBCs were lysed by hypotonic shock, and after washing, cells were suspended in FACS buffer (PBS containing 0.1% BSA and 0.01% sodium azide). Lymph was collected from mice as described previously ([@bib25]). In brief, 10 ml RPMI medium was injected into the peritoneal cavity, and blood was collected by cardiac puncture. The abdominal cavity was cut open under a stereomicroscope (Wild Heerbrugg), and lymph was collected from cisterna chyli using a glass microcapillary tube (Thermo Fisher Scientific). Lymph volume was noted, and lymphocytes were stained and counted by flow cytometry.

Cells were counted using a Beckman Coulter counter, and 1--2 × 10^6^ cells were stained with the indicated fluorochrome-conjugated antibody for 30 min on ice in the dark. For S1P~1~ surface detection, whole thymocytes were stained with rat anti-S1P~1~ mAb or rat IgG~2A~ isotype control (713412; R&D Systems), biotinylated donkey anti--rat IgG (Jackson ImmunoResearch Laboratories, Inc.), and PE-conjugated streptavidin (eBioscience). Samples were acquired using an LSR Fortessa flow cytometer (BD) and FACSDiva software (BD). Data were analyzed with FlowJo software (Tree Star).

For cell sorting and isolation of CD4^+^ thymocytes, all thymocytes were stained with CD4-FITC. For cell sorting and isolation of B220^+^ splenocytes, splenocytes were stained with B220-APC. For isolation of CD45RB^High^CD4^+^ T cells, CD4^+^ cells were negatively enriched from all splenocytes with a CD4 enrichment kit (11415D; Thermo Fisher Scientific) and stained with CD45RB-APC and CD4-FITC. For isolation of thymic endothelial cells, stromal cells were digested with collagenases D and A (Roche) and incubated with CD31, CD45-FITC, and CK8 antibodies followed by incubation with specific fluorescent secondary antibodies. All cells were sorted on a FACSAria II cell sorter (BD).

Immunofluorescence microscopy {#s16}
-----------------------------

Thymuses were embedded in optimal cutting temperature medium, frozen on dry ice, and stored at −80°C. 5-µm cryosections were cut, air dried, and fixed in chilled acetone. Sections were incubated for 1 h in a humidified chamber with 5% serum from the same species in which secondary antibody has been raised. Then, sections were stained with the indicated primary antibody overnight at 4°C, and after washing, sections were stained with respective secondary antibodies for 1 h. Then, sections were counterstained with 100 ng/ml DAPI (Sigma-Aldrich) for 5 min or Hoechst stain solution (Sigma-Aldrich) and mounted in Vectashield mounting medium (Vector Laboratories). Images were captured using a laser-scanning microscope and software (LSM 710; ZEISS). Images were processed using Photoshop CS6 software (Adobe). The medulla was identified by staining with the lectin UEA-1 (Vector Laboratories). CD11c^+^ cell numbers were calculated by counting nucleated CD11c^+^ per unit area.

Plasma and thymus S1P quantification {#s17}
------------------------------------

S1P was extracted from plasma and thymic tissue using a previously described procedure ([@bib3]) with the following modifications: 20-µl plasma samples were diluted in 1 ml PBS, and 100 µl of homogenized thymic tissue lysate was used. To these samples, 10 µl of 62.4 µmol/L of internal standard [d]{.smallcaps}-erythro--sphingosine-d7-1-phosphate (D7-S1P; Avanti Polar Lipids, Inc.) was added. 2 ml of extraction buffer (isopropanol/ethyl-acetate; 15:85, vol/vol) was added, and the sample was vortexed for 30 s. These samples were subjected to centrifugation at 4,000 rpm for 10 min at room temperature. The upper organic phase was collected, and the samples were reextracted after the addition of 100 µl of concentrated formic acid. Organic phase extracts were pooled, and 1.5 ml of organic phase was dried under a constant stream of nitrogen gas. Dried samples were reconstituted in 150 µl of mobile phase B (MeOH containing 1 mM ammonium formate and 0.2% formic acid). For thymic samples, 100 mg of frozen samples were weighed and homogenized in 1 ml of homogenizer buffer (50 mM Tris buffer, pH 7.4, containing 0.25 M sucrose, 25 mM KCl, and 0.5 mM EDTA) using a glass dounce homogenizer. 100 µL of the homogenate was spiked with 10 µl of 62.4 µmol/L of internal standard [d]{.smallcaps}-erythro--sphingosine-d7-1-phosphate (D7-S1P; Avanti Polar Lipids, Inc.). To these samples, 2 ml of tissue S1P extraction buffer (isopropanol/water/ethyl acetate; 30:10:60, vol/vol/vol) was added and vortexed. These samples were sonicated in a bath sonicator for 30 s and briefly vortexed; this step was repeated three times. After sonication, samples were subjected to centrifugation for 10 min at 4,000 rpm at room temperature. The organic phase was collected, and the tissue pellet was reextracted. Organic phases from both extractions were pooled, and 1.5 ml of aliquot was dried under a constant stream of nitrogen and reconstituted in 150 µl of mobile phase B.

For analysis of S1P, a 1290 ultra--high-pressure LC system coupled to a mass spectrometer (6490 Triple Quadrupole; Agilent Technologies) equipped with Jet Stream--electrospray ionization interface (Agilent Technologies) was used. The instrument was operated by Mass Hunter Workstation software. Chromatographic separation was performed with a rapid resolution high definition column (2.1 × 150 mm; 1.8 µm; Zorbax Eclipse Plus C18) equilibrated at 50°C. A binary gradient of mobile phase A (water containing 0.2% formic acid and 2 mM ammonium formate) and B (methanol containing 0.2% formic acid and 1 mM ammonium formate) was delivered at a constant flow rate of 1 ml/min. The total run time was 4 min. The initial gradient was 70% B, increased to 100% B at 3 min, returned to baseline at 3.1 min, and maintained until 4 min.

Analysis was performed using multiple-reaction monitoring mode. The general source settings in the positive ionization modes were as follows: gas temperature, 200_C; gas flow, 16 liter, min_1; nebulizer, 20 psi; sheath gas temperature, 250 \_C; sheath gas flow, 11 liter, min_1; capillary voltage, 3,000 V; and nozzle voltage, 0 V. The fragmentor voltage of 380 V and a dwell time of 200 ms were used for all mass transitions, and both Q1 and Q3 resolutions were set to nominal mass unit resolution. The multiple reaction monitoring transitions used for S1P and D7-S1P were m/z 380.6→264.2 (collision energy, 12 V) and m/z 387.2→271.3 (collision energy, 12 V), respectively. Peak area ratio between target analyte and its internal standard was used for quantitation.

BM chimeras {#s18}
-----------

For BM chimeras, recipients were irradiated with two 6 Gray doses of x-ray total body irradiation separated by 3 h. The source of ionizing radiation was an x-ray generator (RS-2000 Biological Irradiator; Rad Source Technologies, Inc.) operating at 160 kV and 25 mA, yielding an absorbed dose rate of 2.2 Gy/min. 16 h after irradiation, BM was removed by flushing out femoral bones from donor mice with 5 ml of ice-cold RPMI media under sterile conditions. Cells were disaggregated with a 22-gauge needle and filtered through a sterile 40-µm cell strainer, and cells were resuspended in RPMI medium. Mice received 5--10 × 10^6^ BM cells by retroorbital injection. Chimeras were analyzed 7 wk after transplantation.

DC and macrophage isolation {#s19}
---------------------------

CD11b^+^ cells were isolated from BM of SPL^F^ and SPL^MacKO^ mice by a magnetic-activated cell-sorting--based system using CD11b microbeads (130-049-601; Miltenyi Biotec). Resident peritoneal macrophages were isolated as previously described ([@bib32]). CD11b^+^ peritoneal macrophages were isolated using CD11b microbeads. Splenic CD11c^+^ DCs were isolated by digesting whole spleens from SPL^F^ and SPL^DCKO^ mice with collagenase D (Roche) and using CD11c microbeads (130-052-001; Miltenyi Biotec). CD4SP thymocytes were isolated from SPL^F^ and SPL^TCellKO^ mice using a CD4^+^ T Cell Isolation kit (130-104-454; Miltenyi Biotec) following the manufacturer's instructions.

In vitro differentiation of DCs and macrophages {#s20}
-----------------------------------------------

DCs and macrophages were prepared according to a modified protocol described by [@bib24]. In brief, 2 × 10^6^ BM cells from tibia and femur of SPL^F^ and SPL^Mx1KO^ mice were cultured in RPMI 1640, 10% heat-inactivated FBS, β-ME, glutamine, and penicillin/streptomycin supplemented with 100--200 ng/ml GM-CSF (Prospec) for DCs or 100--200 ng/ml M-CSF (Prospec) for macrophages for 6 or 7 d. DCs were matured for one additional day with 100 ng/ml LPS (Sigma-Aldrich).

Quantitative real-time PCR {#s21}
--------------------------

Total RNA was extracted from sorted cell populations using an Aurum total RNA mini kit (Bio-Rad Laboratories) that included DNase I treatment. RT reactions were performed using the iScript cDNA synthesis kit (Bio-Rad Laboratories). Real-time PCR reactions were performed on a thermocycler (ABI 7900HT; Applied Biosystems) according to the manufacturer's instructions. The following primer sets were used: SGPL1 forward, 5′-GAACCGACCTCCTCAAGCTG-3′; SGPL1 reverse, 5′-AGGACACTCCACGCAATGAG-3′; GAPDH forward, 5′-AACTTTGGCATTGTGGAAGG-3′; and GAPDH reverse, 5′-ACACATTGGGGGTAGGAACA-3′. To control for DNA contamination, primers were designed to span at least an intron, and a reaction without RT was performed in parallel for each sample/primer pair. Primer pairs were also tested for linear amplification over two orders of magnitude.

Adoptive transfer of peripheral DCs {#s22}
-----------------------------------

C57BL/6 and SPL^DCKO^ mice were injected subcutaneously with 4 × 10^6^ to 6 × 10^6^ B16 melanoma cells secreting Flt3 ligand to increase DC population of donor mice, as previously described ([@bib26]). B16 melanoma cells secreting Flt3 ligand were provided by L. Fong (University of California, San Francisco, San Francisco, CA). After 10--14 d, mice were euthanized, and DCs were purified by density gradient centrifugation over Optiprep medium (Sigma-Aldrich) by collection of the low-density fraction ([@bib4]). This fraction constituted 70--80% CD11c^+^ cells. In some experiments, isolated cells were stained with 10 mM CMTMR (5-(and-6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine; Invitrogen). Then 60--80 × 10^6^ isolated immature DCs were injected intravenously into SPL^DCKO^ and SPL^F^ littermate controls. Mice were sacrificed 5 d later. The number of mature CD4SP cells in their thymuses was analyzed using an LSR Fortessa flow cytometer (BD). The total number of homed DCs was calculated by multiplying the fraction of CMTMR^+^ events by the total cellularity of the thymus.

Measurement of extracellular D7-S1P uptake {#s23}
------------------------------------------

Mature BMDCs from SPL^F^ and SPL^DCKO^ mice were incubated in 1.5 µM [d]{.smallcaps}-*erythro*--sphingosine-d7-1-phosphate (Avanti Polar Lipids, Inc.) for 0.5, 1, 3, and 6 h. Cells were washed three times with PBS, and D7-S1P was quantified in cell pellets by LC/MS. To study the mechanisms of uptake, BMDCs from SPL^DCKO^ mice were matured for 24 h with 100 ng/ml LPS (Sigma-Aldrich). Mature BMDCs were then incubated for 24 h with control DMSO (Sigma-Aldrich), 10 µM XY-14 (Echelon), 5 µM FTY720 (Sigma-Aldrich), or 80 µM of dynasore (Sigma-Aldrich) before adding 1.5 µM D7-S1P in RPMI (Thermo Fisher Scientific) with 10% FBS and penicillin/streptomycin. After 1-, 3-, and 6-h incubation, the medium was removed, cells were washed three times with PBS, and D7-S1P was quantified by LC/MS. Isolated CD4SP thymocytes from SPL^F^ and SPL^TCellKO^ mice were incubated in 1.5 µM D7-S1P for 0, 3, and 6 h. The medium was removed, cells were washed three times with PBS, and D7-S1P was quantified by LC/MS as described before using C17-S1P as an internal standard.

Statistics {#s24}
----------

Statistical analysis was performed using Prism 6.0 software (GraphPad Software), and results are presented as mean ± SD, as indicated. The mean of two groups was compared by two-tailed unpaired Student's *t* tests. A p-value \<0.05 was considered significant.

We dedicate this manuscript to Alexander Lucas, a brilliant immunologist and treasured colleague.

We are grateful to Nancy Manley for *FoxN1*-Cre mice, Dr. Jean Vacher for CD11b-Cre mice, Dr. Ralf H. Adams for Cdh5(PAC)-CreERT2 mice, Dr. L. Fong for B16-Flt3L melanoma cells, Teresa Klask for expert administrative support, and members of the Saba laboratory for discussion and support. We also thank Dr. Joanna Halkias and Dr. Heather Melichar for their critical reading of the manuscript.

This work was supported by National Institutes of Health (NIH) grants (CA129438) and Swim Across America funds (to J.D. Saba). Confocal images were acquired at the Children\'s Hospital Oakland Research Institute Microimaging Facility supported by an NIH grant (S10RR025472) and the Children\'s Hospital Branches, Inc. S1P measurements were obtained using the Children\'s Hospital Oakland Research Institute Mass Spectrometry Facility supported by an NIH Health grant (S10OD018070).

The authors declare no competing financial interests.

Abbreviations used:CK8cytokeratin 8DPdouble positiveLCliquid chromatographyLPPlipid phosphatase ectoenzymeMSmass spectrometrypoly(I:C)polyinosinic:polycytidylic acidS1Psphingosine-1-phosphateSPsingle positiveSPLS1P lyaseTECthymic epithelial cell

[^1]: J. Zamora-Pineda and A. Kumar contributed equally to this paper.

[^2]: A. Kumar's present address is Dept. of Biochemistry, All India Institute of Medical Sciences, Bhopal 462020, India.
